BHVN
Geode Capital Management’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-1,097,362
| Closed | -$166M | – | 5090 |
|
|
2022
Q3 | $166M | Buy |
1,097,362
+25,237
| +2% | +$3.82M | 0.03% | 528 |
|
|
2022
Q2 | $156M | Buy |
1,072,125
+67,512
| +7% | +$9.84M | 0.02% | 545 |
|
|
2022
Q1 | $119M | Buy |
1,004,613
+43,523
| +5% | +$5.16M | 0.01% | 688 |
|
|
2021
Q4 | $132M | Buy |
961,090
+22,116
| +2% | +$3.05M | 0.02% | 689 |
|
|
2021
Q3 | $130M | Buy |
938,974
+25,524
| +3% | +$3.55M | 0.02% | 666 |
|
|
2021
Q2 | $88.7M | Buy |
913,450
+96,911
| +12% | +$9.41M | 0.01% | 864 |
|
|
2021
Q1 | $55.8M | Buy |
816,539
+79,943
| +11% | +$5.46M | 0.01% | 1138 |
|
|
2020
Q4 | $63.1M | Buy |
736,596
+43,886
| +6% | +$3.76M | 0.01% | 952 |
|
|
2020
Q3 | $45M | Buy |
692,710
+36,174
| +6% | +$2.35M | 0.01% | 976 |
|
|
2020
Q2 | $48M | Buy |
656,536
+49,845
| +8% | +$3.64M | 0.01% | 918 |
|
|
2020
Q1 | $20.6M | Buy |
606,691
+88,876
| +17% | +$3.02M | 0.01% | 1271 |
|
|
2019
Q4 | $28.2M | Buy |
517,815
+195
| +0% | +$10.6K | 0.01% | 1335 |
|
|
2019
Q3 | $21.6M | Buy |
517,620
+43,520
| +9% | +$1.82M | 0.01% | 1428 |
|
|
2019
Q2 | $20.8M | Buy |
474,100
+80,514
| +20% | +$3.53M | 0.01% | 1453 |
|
|
2019
Q1 | $20.3M | Buy |
393,586
+39,939
| +11% | +$2.06M | 0.01% | 1411 |
|
|
2018
Q4 | $13.1M | Buy |
353,647
+82,960
| +31% | +$3.07M | ﹤0.01% | 1593 |
|
|
2018
Q3 | $10.2M | Buy |
270,687
+17,625
| +7% | +$662K | ﹤0.01% | 1905 |
|
|
2018
Q2 | $10M | Buy |
253,062
+75,604
| +43% | +$2.99M | ﹤0.01% | 1863 |
|
|
2018
Q1 | $4.57M | Buy |
177,458
+5,350
| +3% | +$138K | ﹤0.01% | 2290 |
|
|
2017
Q4 | $4.64M | Buy |
172,108
+20,908
| +14% | +$564K | ﹤0.01% | 2251 |
|
|
2017
Q3 | $5.65M | Sell |
151,200
-13,704
| -8% | -$512K | ﹤0.01% | 2125 |
|
|
2017
Q2 | $4.12M | Buy |
+164,904
| New | +$4.12M | ﹤0.01% | 2283 |
|